Pharmacy Report Archives - Page 50 of 148 - Becker's Hospital Review

Teens turn to weight loss drugs | 2 drug trials on clinical hold | Hospital CEO's death post-surgery prompts lawsuit | Walgreens' VillageMD to exit Fla. | UAB pauses IVF

February 22, 2024 BHR Newsletter 1. Nearly 4,000 weight loss drug prescriptions in 2023 were for teens Full story 2. FDA places clinical holds on 2 drug studies Full story 3. Walgreens' VillageMD to exit Florida Full story 4. Health systems…

10 new drug shortages | Simplify hiring of foreign pharmacists: AHA | How a CEO handled a $2B mistake | AbbVie names new CEO | 50K syringe pumps might delay therapy | Vizient's 37 customers

February 21, 2024 BHR Newsletter 1. AHA: Simplify hiring process for foreign pharmacists Full story 2. How a CEO handled a $2B mistake Full story 3. 10 drugs now in shortage Full story 4. Healthcare still isn't out of the…

OU Health settles pharmacy lawsuit | Pharmacists, AMA clash over scope | Gene therapies fizzle in execution | Wegovy scripts for kids on the rise | 6 top healthcare billionaires

February 20, 2024 BHR Newsletter 1. Pharmacists confront AMA's 'scope creep' stance Full story 2. OU Health settles pharmacy lawsuit for $140K Full story 3. Buzz for gene therapies is loud, but drugmakers struggle to get treatments off the ground…

Pharmacy execs seeking a promotion: 2 tips | The rise of 'polypharmacy' | A new safety-net designation? | US mulls spring COVID shot | 1st T cell melanoma drug approved

February 19, 2024 BHR Newsletter 1. Pharmacy leaders seeking higher roles: 2 skills to hone Full story 2. The rise of 'polypharmacy' Full story 3. Employers' waning hesitancy over weight loss drugs Full story 4. Faster resolutions on the backend…

FTC probes GPOs, wholesalers | Cuban sells drugs in shortage to hospitals | 10 systems seeking pharmacy leaders | Payer M&A derails | Healthcare layoffs in 14 numbers

February 15, 2024 BHR Newsletter 1. FTC probes whether GPOs, wholesalers cause drug shortages Full story 2. Mark Cuban drug company unveils new offering for hospitals Full story 3. Discontinued asthma drug stirs frustrations Full story 4. Experts are more…

6 Ozempic updates | Medical supply scam could cost US $2B | 1st severe frostbite drug approved | Pa. physician sentenced in patient death | 6 promising cancer vaccines

February 14, 2024 BHR Newsletter 1. Alleged Medicare catheter billing scam could cost $2B Full story 2. FDA approves 1st treatment for severe frostbite Full story 3. 6 Ozempic updates Full story 4. Some hospitals struck a balancing act in…

CDC to scale Mich. system's pharmacy program | Aspiring pharmacist union rebukes CVS' profits | Dallas system, Pfizer partner | 12 hospitals cutting jobs

February 13, 2024 BHR Newsletter 1. CDC seeks to expand U of Michigan's hypertension pharmacy program model Full story 2. UT Southwestern partners with Pfizer on RNA delivery tech Full story 3. Aspiring pharmacist union slams CVS' $2B earnings Full…

Gyms reply to Ozempic side effect | Phenylephrine's popularity problem | 10 most lucrative healthcare cos. | Pharmacy leaders admit to $65M scheme | A cancer drug that may treat Parkinson's

February 12, 2024 BHR Newsletter 1. Gyms, nutrition startups race to combat Ozempic muscle loss Full story 2. If FDA swipes common decongestant, supply issues expected Full story 3. Sutter hospital employee stabbed, man charged Full story 4. Adventist Health deconstructed the…

Kaiser's pharmacy cuts emissions | 10 systems seeking pharmacy leaders | A 4-day workweek in healthcare | Mercy hospital to move pharmacy

February 8, 2024 BHR Newsletter 1. Kaiser's playbook for slashing carbon emissions Full story 2. Joint Commission's authority to accredit home infusion therapy services renewed Full story 3. Weight loss drugs tied to fewer anxiety, depression cases: Study Full story…

Top 20 schools by 1st-time NAPLEX pass rates | Zepbound succeeds in liver disease trial | Drug shortages cost hospitals $550M: AHA | Amazon cuts pharmacy jobs | 2 cancer vaccine candidates

February 7, 2024 BHR Newsletter 1. Top 20 pharmacy schools for first-time NAPLEX pass rates Full story 2. Zepbound, Mounjaro show potential for fatty liver disease Full story 3. Amazon cuts jobs in pharmacy, other healthcare divisions Full story 4.…